CDK12/13 inhibition disrupts nucleolar morphology and promotes aberrant expression of IGS transcripts
Rodolfo Bortolozo Serafim, Marina P. Volegova, Matt L. Harlow, Ushashi Banerjee, Cibele Campos Cardoso, Sanjukta Das, Bandana Sharma, Gabriel E. Zentner, Peter C. Scacheri, Tinghu Zhang, Nathanael S. Gray, Stephen Buratowski, Rani E. George
This study shows CDK12/13 inhibition disrupts nucleolar structure and causes aberrant IGS rRNA transcript expression due to impaired processing and degradation.
bioRxiv · Mar 1, 2025 · PreprintCancer Biology